Suppression of immune system genes by methylprednisolone in exacerbations of multiple sclerosis: Preliminary results

By Airla* Nina   Luomala* Mari   Elovaara Irina   Kettunen Eeva   Knuutila Sakari   Lehtimäki Terho  

Journal of Neurology, Vol. 251, Iss. 10, 2004-10 ,pp. : 1215-1219

Springer Publishing Company

Access to resources Recommend Favorite

Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis

By Ehrenreich Hannelore  

Brain, Vol. 130, Iss. 10, 2007-10 ,pp. : 2577-2588

Oxford University Press

Access to resources Recommend Favorite

Monoclonal Antibodies as Disease Modifying Therapy in Multiple Sclerosis

By Longbrake Erin   Parks Becky   Cross Anne  

Current Neurology and Neuroscience Reports, Vol. 13, Iss. 11, 2013-11 ,pp. : 1-9

Springer Publishing Company

Access to resources Recommend Favorite

Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): A comparison of interferon beta therapies for relapsing-remitting multiple sclerosis

By Limmroth Volker   Malessa Rolf   Zettl Uwe   Koehler Jürgen   Japp Gudrun   Haller Peter   Elias Wolfgang   Obhof Winfried   Viehöver Andrea   Meier Uwe   Brosig Arne   Hasford Joerg   Putzki Norman   Kalski Gabriele   Wernsdörfer Colin  

Journal of Neurology, Vol. 254, Iss. 1, 2007-01 ,pp. : 67-77

Springer Publishing Company

Access to resources Recommend Favorite

Central Serous Chorioretinopathy Following Pulse Corticosteroid Therapy in Multiple Sclerosis

By Bahadir Ayse Ebru   Bozkurt Tahir Kansu   Unal Melih   Colakoglu Kadir   Tireli Hulya  

Neuro-Ophthalmology, Vol. 36, Iss. 4, 2012-08 ,pp. : 135-137

Informa Healthcare

Access to resources Recommend Favorite